产品详情
简单介绍：
Anti-phospho-Bid (Ser65)抗体产品质量稳定，实验效果明显，货期快，价格优惠，欢迎垂询订购！我公司长期供应**组化抗体、WB抗体、**组化试剂盒和抗体试验所需全部相关试剂、荧光标记抗体、单克隆抗体、多克隆抗体、各种标记的二抗IgG/IgM/IgD/IgA等科研实验抗体。Anti-phospho-Bid (Ser65)抗体用于**组化实验,WB实验,相应的标记抗体有HRP标记抗体,FITC标记,BIO等。
详情介绍：
Rabbit Anti-phospho-Bid (Ser65)
Cat. Number:
Anti-phospho-Bid (Ser65)抗体KL-5230R
Quantity size:
0.1ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Bid, a BH3 domain containing proapoptotic Bcl2 family member, is localized in the cytosolic fraction of cells as an inactive precursor. Its active form is generated upon proteolytic cleavage by caspase 8 in the Fas signaling
Anti-phospho-Bid (Ser65)抗体pathway. Cleaved Bid translocates to mitochondria and releases its potent proapoptotic activity, which in turn induces cytochrome c release and mitochondrial damage. The cytochrome c releasing activity of Bid was antagonized by Bcl2. Mutation in the SH3 domain can diminish the cytochrome c releasing activity. In animal model studies, Bid deficient mice are found resistant to the lethal effects of death factor signals relayed through Fas.
Also known as:
Bid (phospho S65);
Anti-phospho-Bid (Ser65)抗体p-Bid (phospho S65); BH3 interacting domain death agonist; p22 BID; BID;) BH3-interacting domain death agonist; AltName: BH3-interacting domain death agonist p15; BH3-interacting domain death agonist p13; p13 BID; BH3-interacting domain death agonist p11; p11 BID.
Specificity:
●
Rabbit Polyclonal IgG,
Anti-phospho-Bid (Ser65)抗体affinity purified by Protein A.
●
Reacts with: Rat, .
●
Immunogen: KLH conjugated Synthesised phosphopeptide derived from rat Bid around the phosphorylation site of Ser65.
●
Predicted Molecular Weight: 21kDa.
Storage:
Shipped at 4℃,
Anti-phospho-Bid (Ser65)抗体Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl303Mu01 半乳糖凝集素3(GAL3)多克隆抗体 Polyclonal Antibody to Galectin 3 (GAL3)
kl303Ra01 半乳糖凝集素3(GAL3)多克隆抗体 Polyclonal Antibody to Galectin 3 (GAL3)
kl303Rb51 半乳糖凝集素3(GAL3)多克隆抗体 Polyclonal Antibody to Galectin 3 (GAL3)
kl303Si01 半乳糖凝集素3(GAL3)多克隆抗体 Polyclonal Antibody to Galectin 3 (GAL3)
kl304Bo01 半乳糖凝集素4(GAL4)多克隆抗体 Polyclonal Antibody to Galectin 4 (GAL4)
kl304Hu01 半乳糖凝集素4(GAL4)多克隆抗体 Polyclonal Antibody to Galectin 4 (GAL4)
kl304Mu01 半乳糖凝集素4(GAL4)多克隆抗体 Polyclonal Antibody to Galectin 4 (GAL4)
kl304Po01 半乳糖凝集素4(GAL4)多克隆抗体 Polyclonal Antibody to Galectin 4 (GAL4)
kl304Ra01 半乳糖凝集素4(GAL4)多克隆抗体 Polyclonal Antibody to Galectin 4 (GAL4)
kl304Rb51 半乳糖凝集素4(GAL4)多克隆抗体 Polyclonal Antibody to Galectin 4 (GAL4)
kl306Bo01 组织蛋白酶L(CTSL)多克隆抗体 Polyclonal Antibody to Cathepsin L (CTSL)
kl306Fi01 组织蛋白酶L(CTSL)多克隆抗体 Polyclonal Antibody to Cathepsin L (CTSL)
kl306Hu01 组织蛋白酶L(CTSL)多克隆抗体 Polyclonal Antibody to Cathepsin L (CTSL)
kl306Mu01 组织蛋白酶L(CTSL)多克隆抗体 Polyclonal Antibody to Cathepsin L (CTSL)
kl306Po01 组织蛋白酶L(CTSL)多克隆抗体 Polyclonal Antibody to Cathepsin L (CTSL)
kl306Ra01 组织蛋白酶L(CTSL)多克隆抗体 Polyclonal Antibody to Cathepsin L (CTSL)
kl307Hu01 半乳糖凝集素7(GAL7)多克隆抗体 Polyclonal Antibody to Galectin 7 (GAL7)
kl307Mu01 半乳糖凝集素7(GAL7)多克隆抗体 Polyclonal Antibody to Galectin 7 (GAL7)
kl307Ra01 半乳糖凝集素7(GAL7)多克隆抗体 Polyclonal Antibody to Galectin 7 (GAL7)
kl308Bo01 半乳糖凝集素8(GAL8)多克隆抗体 Polyclonal Antibody to Galectin 8 (GAL8)
kl308Hu01 半乳糖凝集素8(GAL8)多克隆抗体 Polyclonal Antibody to Galectin 8 (GAL8)
kl308Mu01 半乳糖凝集素8(GAL8)多克隆抗体 Polyclonal Antibody to Galectin 8 (GAL8)
kl308Po01 半乳糖凝集素8(GAL8)多克隆抗体 Polyclonal Antibody to Galectin 8 (GAL8)
kl308Ra01 半乳糖凝集素8(GAL8)多克隆抗体 Polyclonal Antibody to Galectin 8 (GAL8)
kl309Bo01 半乳糖凝集素9(GAL9)多克隆抗体 Polyclonal Antibody to Galectin 9 (GAL9)
kl309Ca01 半乳糖凝集素9(GAL9)多克隆抗体 Polyclonal Antibody to Galectin 9 (GAL9)
kl309Hu01 半乳糖凝集素9(GAL9)多克隆抗体 Polyclonal Antibody to Galectin 9 (GAL9)
